Q: Would you consider REGN to be a buy at this level or is there a better choice in the sector?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: I finally have a small gain on Gilead. Would you continue to hold or switch to some other stock like ABBV or ZTS or some other pharma or biotech stock you like? Thank you. Cheers
Q: Which stock has the most torque AND or WELL.I have a position in WELL.Wondering if I should add to WELL or start a new position in AND.This would be for a long term hold.
Q: Hi Folks,
in my RRSP account I have PFE and ABBV - I am thinking of selling some PFE and adding to ABBV to bring each weighing to 10%. Currently 14% and 7%. Would you recommend ABBV over PFE at this time?
Thanks
in my RRSP account I have PFE and ABBV - I am thinking of selling some PFE and adding to ABBV to bring each weighing to 10%. Currently 14% and 7%. Would you recommend ABBV over PFE at this time?
Thanks
Q: I've just started to look into GUD and I'm trying to understand why the shares have been trading down since 2017. From what I can see, earnings and revenue have been climbing, they've beaten EPS estimates the last 5 quarters, insiders are buying, the company is buying back shares, management has a good track record....what is the bull thesis or what am I missing?
-
Illumina Inc. (ILMN)
-
Telo Genomics Corp. (TELO)
-
Invitae Corporation (NVTA)
-
Editas Medicine Inc. (EDIT)
-
CRISPR Therapeutics AG (CRSP)
-
ARK Genomic Revolution ETF (ARKG)
Q: The genome space seems to have taken a hit and I'd like to add some to my portfolio. Can you give me 3 to 5 Canadian or US stocks going forward that you believe have the highest potential of gains( I realise this would also be subject to the most risk) for a 5 plus year hold.
Also 3 to 5 stocks from Canada or US that you feel should be held for long term exposure.
Thank you.
Also 3 to 5 stocks from Canada or US that you feel should be held for long term exposure.
Thank you.
-
Intuitive Surgical Inc. (ISRG)
-
AbbVie Inc. (ABBV)
-
Johnson & Johnson (JNJ)
-
Medtronic plc. (MDT)
-
Merck & Company Inc. (MRK)
-
Pfizer Inc. (PFE)
-
Stryker Corporation (SYK)
-
Veeva Systems Inc. Class A (VEEV)
-
WELL Health Technologies Corp. (WELL)
-
DexCom Inc. (DXCM)
-
Curaleaf Holdings Inc. Subordinate Voting Shares (CURA)
-
CareRx Corporation (CRRX)
Q: Hello Peter and Staff
So I am a slow learner and a bad listener.....in order to add AND to my health care basket, Chartwell is gone.......I did not feel like adding $ for $ so have some of CSH proceeds left to top up a position or 2 in my basket....Please list 1, 2 ,3 in priority of your preferences above and if you see any you would not advise be kept, please say so and why.
Thanks for all you do
Dennis
So I am a slow learner and a bad listener.....in order to add AND to my health care basket, Chartwell is gone.......I did not feel like adding $ for $ so have some of CSH proceeds left to top up a position or 2 in my basket....Please list 1, 2 ,3 in priority of your preferences above and if you see any you would not advise be kept, please say so and why.
Thanks for all you do
Dennis
-
Teladoc Health Inc. (TDOC)
-
Acadia Healthcare Company Inc. (ACHC)
-
Intra-Cellular Therapies Inc. (ITCI)
-
Magellan Health Inc. (MGLN)
-
CloudMD Software & Services Inc. (DOC)
Q: Following the pandemic there is a significant increase in mental health issues. Would you suggest any company or companies which are helping in addressing this issue and which you think have a good opportunity to grow. Thanks.
Regards,
Shyam
Regards,
Shyam
-
AbbVie Inc. (ABBV)
-
The Cigna Group (CI)
-
Knight Therapeutics Inc. (GUD)
-
WELL Health Technologies Corp. (WELL)
-
MEDIFAST INC (MED)
Q: I would like to double my Health sector % as recommended by Portfolio Analytics. I could also increase US portion of my portfolio but either Can or US is fine.
Current holdings and percentage of total portfolio are:
GUD (.75%), WELL (2.85%), ABBV (.81%)
Could increase existing holdings but have also been looking at US stocks CI and MED.
Your thoughts on approach and recommendations, including additions/deletions/other equities I have not mentioned would be appreciated. Dividend is not essential.
As always, many thanks.
Current holdings and percentage of total portfolio are:
GUD (.75%), WELL (2.85%), ABBV (.81%)
Could increase existing holdings but have also been looking at US stocks CI and MED.
Your thoughts on approach and recommendations, including additions/deletions/other equities I have not mentioned would be appreciated. Dividend is not essential.
As always, many thanks.
Q: Cipher had pretty good numbers in the 2nd q. This company may have turned the corner. The new ceo ( joined in 2019) Mull is a smart dude who made a lot of shareholders money on CML Healthcare. This one may be one to watch.
Q: did you have a chance to listen to the cc to see what accounts for the quarter results? Thx
Q: Thoughts on the quarter?
Thanks,
Dave
Thanks,
Dave
Q: On Aug 13, you answered questions regarding Well as " As WELL stock did well, the stock price set in the equity component of the deal was $11.80 (up from $9.80). Circle had very strong growth. " What did that mean? Can you provide some background about above statement? What is equity component in the sentence mean and where did the $11.8 price came from?
Thanks,
Thanks,
Q: The share price for Vitahub Corp has dropped about 30% from the peak since June 2021 and it seems to continue dropping. What are the reasons for the downtrend? Is this stock a buy, hold or sell considering the next 1 to 2 year performance?
Q: Comment on earnings
Q: After hearing the conference call do you have any further comments on WELL.
Q: what do you think of ibbq as an investment in healthcare
thx
judy
thx
judy
Q: Please comment on earnings
Q: Hello just wondered what you thought of cvac
Q: This company seems to have reasonable ROE (just under 20) and good growth but has sold off with several large blocks transacting recently despite positive analyst coverage. It reports this week so I don't plan to jump into a position but I wanted 5i's opinion on whether mid $30's represents an attractive entry point for a company that has exposure to a variety of Pharma companies? Would it be a buy, sell or hold for you and what would it take in terms of a news event or drop in price to make it a buy? What do you like and/or dislike about the company?
Thanks!
Thanks!